Valuation: Curiosis, Inc.

Market Cap 13TCr 9.48Cr 8.17Cr 7.74Cr 7.01Cr 13Cr 905.95Cr 13Cr 92Cr 35Cr 460.91Cr 36Cr 35Cr 1.46TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 11Cr 81.1T 69.88T 66.17T 59.97T 1L 77.48L 1L 8L 3L 39.42L 3L 3L 1.25Cr EV / Sales 2026 *
7.06x
EV / Sales 2027 * 4.55x
Free-Float
85.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.12%
1 week-2.80%
Current month-8.66%
1 month-29.88%
3 months-38.97%
6 months-75.86%
Current year-66.00%
1 week 7,990
Extreme 7990
8,790
1 month 7,990
Extreme 7990
11,710
Current year 7,990
Extreme 7990
44,000
1 year 7,990
Extreme 7990
48,200
3 years 7,990
Extreme 7990
48,200
5 years 7,990
Extreme 7990
48,200
10 years 7,990
Extreme 7990
48,200
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2015
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/01/2015
Director/Board Member 57 01/12/2016
Director/Board Member 56 01/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-2.80% - - 9.48Cr
+1.10%-0.65%+27.19%+19.36% 23TCr
-0.19%-3.62%+5.31%-20.72% 14TCr
+2.41%+0.67%-17.91%+21.95% 13TCr
-0.28%-10.08%-58.15%-19.21% 6.23TCr
+2.37%+1.32%-18.16%-13.62% 4.94TCr
-2.77%-6.15%+8.77%+15.31% 4.86TCr
+2.66%-2.61%+19.22%+29.53% 4.14TCr
+1.67%-0.25%+38.24%+52.80% 4.01TCr
-0.60%-4.41%-19.20%+49.15% 3.12TCr
Average +0.70%-3.40%-1.63%+14.95% 7.7TCr
Weighted average by Cap. +0.80%-2.40%+2.83%+10.48%

Financials

2026 *2027 *
Net sales 1.54TCr 1.15Cr 98.99L 93.73L 84.95L 1.59Cr 109.76Cr 1.6Cr 11Cr 4.28Cr 56Cr 4.31Cr 4.22Cr 176.45Cr 2.39TCr 1.78Cr 1.54Cr 1.45Cr 1.32Cr 2.47Cr 170.34Cr 2.49Cr 17Cr 6.64Cr 87Cr 6.7Cr 6.55Cr 273.84Cr
Net income - -
Net Debt -1.84TCr -1.37Cr -1.18Cr -1.12Cr -1.02Cr -1.9Cr -131.14Cr -1.91Cr -13Cr -5.11Cr -67Cr -5.16Cr -5.04Cr -210.82Cr -1.84TCr -1.37Cr -1.18Cr -1.12Cr -1.02Cr -1.9Cr -131.14Cr -1.91Cr -13Cr -5.11Cr -67Cr -5.16Cr -5.04Cr -210.82Cr
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
-
Date Price Change Volume
11/26/11 ₩8,330.00 +0.12% 1,19,002
10/26/10 ₩8,320.00 -0.60% 65,690
09/26/09 ₩8,370.00 +1.33% 53,628
08/26/08 ₩8,260.00 -5.71% 1,12,262
07/26/07 ₩8,760.00 +2.22% 60,255
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!